აბსტრაქტები

Reversal of liver damage among HCV infected persons with advanced liver disease: Two-year follow-up from the HCV elimination program, Georgia

Long-term health outcome among HCV patients with advanced liver fibrosis treated through HCV elimination program in Georgia

Attitude of staff regarding integrated hepatitis C treatment at eight harm reduction centers in Georgia

Outcomes of hepatitis C antiviral treatment among PWIDs in Georgia

Low HCV reinfection rate after treatment in people who infect drugs (PWID) from a prospective cohort in Tbilisi, Georgia

Factors associated with sustained viral response among HCV genotype 2 patients treated with direct acting antivirals within HCV elimination program in Georgia

Characteristics of patients with missing sustained virologic response (SVR) data, elimination program in Georgia

Approaches to providing hepatitis C viremia testing to people who inject drugs in Georgia